Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2026-03-17 @ 5:01 AM
Study NCT ID:
NCT02977494
Status:
COMPLETED
Last Update Posted:
2022-05-31
First Post:
2016-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2016-000433-51
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None